Search results
Want Weight Loss Pills? Here's How to Ask Your Doctor For Them
MediaFeed via AOL· 5 days agoWhether it’s with your spouse, your BFF or your doctor, weight loss can be a tricky topic of...
Hims & Hers Will Sell Wegovy-Like Weight Loss Drugs for $199
Gizmodo via Yahoo Finance· 1 day agoThe millennial-skewed telehealth platform Hims & Hers announced Monday that is now offering...
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 3 hours agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...
Weighing the Pros & Cons of 4 Common ED Pills
MediaFeed via AOL· 6 days agoOver the last 25 years, (ED) medications such as Viagra and others have become common and normal pieces of bedroom tool kit. These little pills have...
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
Zacks· 7 days agoFree Report) , a clinical-stage company focused on developing novel therapeutics for metabolic and...
FOX23 Investigates: How medication to treat diabetes could help with fertility
FOX23 News· 5 days agoPopular diabetes drugs are helping women struggling with fertility be able to get pregnant. FOX23 found out the medication is so successful in helping them lose weight, they're ...
Are Wellbutrin Dosages Different For Anxiety And Depression?
MediaFeed via AOL· 3 days agoThe saying “knowledge is power” applies well in certain situations — like becoming a leader in your...
Survey Suggests 1 in 8 US Adults May Have Used a GLP-1 Drug
Medscape· 6 days agoA KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took...
Evofem Biosciences Announces Financial Results for the First Quarter of 2024
FOX 4 Kansas City· 6 days agoThe company behind the hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate), Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCQB: EVFM) today announced ...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
The Longview News-Journal· 4 days ago- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)